Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU526207B2 - Amino acid solutions as food for patients with cancer - Google Patents
[go: Go Back, main page]

AU526207B2 - Amino acid solutions as food for patients with cancer - Google Patents

Amino acid solutions as food for patients with cancer

Info

Publication number
AU526207B2
AU526207B2 AU50368/79A AU5036879A AU526207B2 AU 526207 B2 AU526207 B2 AU 526207B2 AU 50368/79 A AU50368/79 A AU 50368/79A AU 5036879 A AU5036879 A AU 5036879A AU 526207 B2 AU526207 B2 AU 526207B2
Authority
AU
Australia
Prior art keywords
cancer
patients
food
amino acid
acid solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU50368/79A
Other versions
AU5036879A (en
Inventor
Kohi Ozeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU5036879A publication Critical patent/AU5036879A/en
Application granted granted Critical
Publication of AU526207B2 publication Critical patent/AU526207B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50368/79A 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer Expired AU526207B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient
JP10874978 1978-09-04

Publications (2)

Publication Number Publication Date
AU5036879A AU5036879A (en) 1980-03-13
AU526207B2 true AU526207B2 (en) 1982-12-23

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50368/79A Expired AU526207B2 (en) 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer

Country Status (10)

Country Link
JP (1) JPS5535049A (en)
AU (1) AU526207B2 (en)
CA (1) CA1134275A (en)
CH (1) CH642541A5 (en)
DE (1) DE2935709C2 (en)
FR (1) FR2434622A1 (en)
GB (1) GB2029220B (en)
IT (1) IT1194844B (en)
NL (1) NL190266C (en)
SE (1) SE448679B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
FR2508797B1 (en) * 1981-07-03 1986-03-14 Charles Chany MEDICINAL PRODUCT COMPRISING THE REACTION OF A C1 TO C6 CARBOXYLIC ACID ON A BASIC AMINO ACID
DE3329253A1 (en) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Use of an amino acid mixture for the control of, in particular, lymphadenomas
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (en) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell MEDICINAL SOLUTION CONTAINING AMINOSAUR SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES AND METHOD FOR THE PRODUCTION THEREOF
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (en) * 1985-12-19 1988-11-10 Centre Nat Rech Scient METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
DE69229910T2 (en) * 1991-10-07 2000-04-20 Otsuka Pharmaceutical Factory, Inc. ENTERAL PREPARATIONS FOR CANCER THERAPY
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (en) * 1992-08-29 1994-03-03 Wella Ag Hair setting agent based on lignin or lignin derivatives and dihydroxypropyllignin
JP2930723B2 (en) * 1992-11-19 1999-08-03 アンティキャンサー インコーポレーテド Use of methioninase as an antitumor agent in antimethionine chemotherapy
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (en) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Composition containing amino acids and trace elements and showing antitumor and antihypoxic activity
CA2260886A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (en) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Antitumor agent
EP1163904B1 (en) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium
DE60028376T2 (en) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (en) * 2001-10-05 2003-04-17 Tetsuro Asao Immune system activators
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (en) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
DK1909600T3 (en) * 2005-07-29 2012-07-30 Tima Foundation Composition for moderation of alcohol metabolism and to reduce the risk of alcohol-caused diseases
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
EP2156188B1 (en) 2007-03-28 2021-05-05 University of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
JP2011523626A (en) * 2008-04-24 2011-08-18 ユニバーシティー オブ サウザン カリフォルニア，ユーエスシー スティーブンズ Dietary compositions and methods for protecting against chemotherapy, radiation therapy, oxidative stress, and aging
KR101919747B1 (en) * 2011-02-17 2018-11-20 각꼬호우진 구루메 다이가쿠 Potentiator of antitumor activity of chemotherapeutic agent
JP2016117702A (en) * 2014-12-22 2016-06-30 武輝 山田 Method for destroying cancer cells
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
MX2020001765A (en) 2017-08-14 2020-07-29 Axcella Health Inc Amino acid for the treatment of liver disease.
CN112839643A (en) 2018-06-20 2021-05-25 胺细拉健康公司 Compositions and methods for treating fatty infiltration in muscle
IT201900002109A1 (en) 2019-02-13 2020-08-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE TREATMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM
IT202000000442A1 (en) 2020-01-13 2021-07-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF SIDE EFFECTS OF CHEMOTHERAPY
IT202000000454A1 (en) * 2020-01-13 2021-07-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (en) * 1968-05-09 1972-04-10 Astra Ab Process for the preparation of an infusion solution of essential amino acids for intravenous delivery in uremic conditions
SU423304A3 (en) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (en) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Agents for the treatment and prevention of liver diseases and muscular insufficiency
DE2530246A1 (en) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE
DE2531204C2 (en) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-amino acid mixtures for parenteral or oral nutrition

Also Published As

Publication number Publication date
NL190266C (en) 1994-01-03
DE2935709A1 (en) 1980-03-13
GB2029220B (en) 1983-03-30
CH642541A5 (en) 1984-04-30
GB2029220A (en) 1980-03-19
AU5036879A (en) 1980-03-13
NL190266B (en) 1993-08-02
SE7907316L (en) 1980-03-05
DE2935709C2 (en) 1986-02-06
CA1134275A (en) 1982-10-26
IT1194844B (en) 1988-09-28
FR2434622B1 (en) 1983-04-15
JPS6154007B2 (en) 1986-11-20
IT7905216A0 (en) 1979-09-03
JPS5535049A (en) 1980-03-11
FR2434622A1 (en) 1980-03-28
SE448679B (en) 1987-03-16
NL7906620A (en) 1980-03-06

Similar Documents

Publication Publication Date Title
AU526207B2 (en) Amino acid solutions as food for patients with cancer
AU530380B2 (en) Amino acid derivatives as antihypertensives
AU508419B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU6412280A (en) Imidazole-5-acetic acid derivatives
AU515455B2 (en) Acid tinplating solution
AU4413779A (en) Modified azulmic acid
AU538584B2 (en) Cinnamic acid derivatives
AU531501B2 (en) 3-quinoline-carboxylic acid
AU541322B2 (en) 6-beta-halopenicillanic acid derivatiges
AU526877B2 (en) Phenyl-alkanoic acid derivative
AU518251B2 (en) L-halomethyl amino acid derivatives
AU521126B2 (en) 1-naphthyl-acetic acid derivatives
AU5676780A (en) Benzodioxincarboxylic acid derivatives
AU5863380A (en) Acid derivatives
AU4668179A (en) N,n-dimethyl-0-pyrazolyl-carbamic acid esters
AU533620B2 (en) Pyrrolidinyl-sulfamoylbenzoic acid derivatives
AU537900B2 (en) Dihydronicotinic acid derivatives
AU5135679A (en) Preparing terephthalic acid
AU4575479A (en) 4-halo etianic acid derivatives
AU536508B2 (en) Aziridine-2-carboxylic acid
AU5758980A (en) Clauulanic acid derivatives
AU526380B2 (en) 2-isoxazoline-5-acetic acid derivatives
AU530432B2 (en) Amino acid treatment
AU5210679A (en) O-ethyl-s-n-propyl-dithiophosphoryloxy-acetic acid n-methyl- anilide
AU516258B2 (en) Thiopropanoyl amino acid derivatives

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired